trial · primary record
Orelabrutinib
Multiple Sclerosis (MS) Primary Progressive
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 705 |
| Primary completion | 2030-07 |
| Primary endpoint | Time to onset of composite confirmed disability progression (cCDP) , confirmed over at least 12 weeks (12-week cCDP) |
| Registry ID | NCT07067463 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:31:43.013Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07067463
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.